The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Twitter Is Key Learning, Networking Tool for Rheumatologists

Twitter Is Key Learning, Networking Tool for Rheumatologists

June 15, 2015 • By Thomas R. Collins

  • Tweet
  • Email
Print-Friendly Version / Save PDF
YS PRYKHODOV/SHUTTERSTOCK.COM

Image Credit: YS PRYKHODOV/SHUTTERSTOCK.COM

Jonathan Hausmann, MD, a pediatric and adult rheumatology fellow at Beth Israel Deaconess Medical Center and Boston Children’s Hospital, remembers seeing a patient with a red, swollen and tender big toe early in his fellowship and diagnosing his patient with gout.

You Might Also Like
  • Essentials for Your Social Networking Tool Box
  • ACR Announces New Social Networking Opportunities
  • Doctors Who Take Pharmaceutical Money Use Twitter to Hype Drugs
Explore This Issue
June 2015
Also By This Author
  • Diagnosing Anti-MOG Autoimmune Encephalomyelitis

He was happy to be able to help the patient, and he called in a prescription for colchicine, a standard gout treatment.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

In the morning, he got a call from the pharmacy: They didn’t fill the patient’s prescription because it adversely interacts with another of the man’s medications, atorvastatin.

Dr. Hausmann was unaware of this interaction, but several sources reported that the medications had the potential for adverse reactions and should be avoided. He paged his attending physician, but it took a while to hear back.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

In the meantime, he turned to Twitter for help, receiving tips from practicing rheumatologists that directly affected his clinical care.

Social Media & Medicine

More and more doctors are finding Twitter to be a fertile ground for learning, for keeping in touch with colleagues, and staying tuned in to patient attitudes and concerns. And it occasionally has a clear effect on how they treat patients.

Social media isn’t new, of course, but while Twitter for some doctors is a daily routine, as standard as seeing patients in clinic, the uptake has been very slow among scores of other doctors who question the value of Twitter or distrust it. So even as physician Twitter users trade thoughts about protocols with one another and broaden their insights into their profession far away from big conferences, strengthening bonds with each other in the process, many others are completely uninvolved.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Hausmann says he began using Twitter a year ago, figuring he’d likely reap some benefit.

“If you follow a rheumatology doctor that you know and trust … it’s just like calling a friend and asking for advice,” he says. Except with Twitter, it’s more efficient.

Back to the Case

In the case of the patient with gout, he quickly received responses. After receiving the fifth tweeted response saying that experience had shown that patients could in fact take colchicine and atorvastatin together, Dr. Hausmann was swayed.

“I was convinced that it was probably OK for my patient to take this medicine,” Dr. Hausmann says. “I called CVS, and I said, ‘You know what? I want you to give him this medicine anyway because the benefits greatly outweigh the risks.’”

‘You can get into trouble driving a car. That doesn’t mean you shouldn’t be driving a car. … You just have to be smart about what you do.’

The Benefits

Dr. Hausmann conducted a small survey of 37 doctors who are active on Twitter, asking about the benefits they get from the app. Physicians reported five main benefits. They say Twitter helps them:

  • Stay up to date with the medical literature;
  • Teach (e.g., by sending links to patients and students) and learn;
  • Better understand patients;
  • Stay connected with other physicians; and
  • Be better physicians overall.

Rheumatology Journal Club

In late January, rheumatologists from around the world participated in the first-ever Twitter-based Rheumatology Journal Club. The chosen article was a study about lupus nephritis treatment. To follow the conversation, participants use the hashtag “#rheumjc” at the end of all their tweets. The “sessions” were held at two different times to take into account time differences and allow for broader global input. About 50 participants from 14 countries—even some nephrologists—gave their take on the findings and how it would or wouldn’t impact their care. More than 500 comments were made during the two hour-long sessions.

Pages: 1 2 3 | Single Page

Filed Under: Technology Tagged With: Education, Networking, patient care, rheumatologist, Social Media, TwitterIssue: June 2015

You Might Also Like:
  • Essentials for Your Social Networking Tool Box
  • ACR Announces New Social Networking Opportunities
  • Doctors Who Take Pharmaceutical Money Use Twitter to Hype Drugs
  • How the Mayo Clinic Maximizes Learning Opportunities Through Social Media

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)